Robeco Institutional Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $208M | Sell |
2,008,760
-340,684
| -15% | -$30.4M | 0.26% | 93 |
|
|
2026
Q1 | $169M | Sell |
2,349,444
-989,300
| -30% | -$76.2M | 0.24% | 114 |
|
|
2025
Q4 | $265M | Buy |
3,338,744
+243,501
| +8% | +$19.2M | 0.38% | 55 |
|
|
2025
Q3 | $233M | Buy |
3,095,243
+432,132
| +16% | +$29.6M | 0.34% | 72 |
|
|
2025
Q2 | $184M | Buy |
2,663,111
+2,372,121
| +815% | +$156M | 0.3% | 79 |
|
|
2025
Q1 | $19.7M | Buy |
290,990
+73,583
| +34% | +$4.4M | 0.04% | 334 |
|
|
2024
Q4 | $9.76M | Sell |
217,407
-252,890
| -54% | -$14.2M | 0.02% | 450 |
|
|
2024
Q3 | $29.6M | Sell |
470,297
-16,681
| -3% | -$973K | 0.06% | 275 |
|
|
2024
Q2 | $28.8M | Buy |
486,978
+77,266
| +19% | +$4.83M | 0.06% | 266 |
|
|
2024
Q1 | $32.7M | Sell |
409,712
-169,132
| -29% | -$12.9M | 0.07% | 261 |
|
|
2023
Q4 | $45.7M | Sell |
578,844
-31,472
| -5% | -$2.24M | 0.11% | 196 |
|
|
2023
Q3 | $42.6M | Sell |
610,316
-68,712
| -10% | -$4.87M | 0.11% | 196 |
|
|
2023
Q2 | $46.9M | Sell |
679,028
-824,472
| -55% | -$58.7M | 0.12% | 184 |
|
|
2023
Q1 | $112M | Sell |
1,503,500
-201,237
| -12% | -$16.9M | 0.3% | 90 |
|
|
2022
Q4 | $159M | Sell |
1,704,737
-92,902
| -5% | -$8.96M | 0.46% | 58 |
|
|
2022
Q3 | $171M | Buy |
1,797,639
+3,387
| +0.2% | +$335K | 0.55% | 43 |
|
|
2022
Q2 | $166M | Buy |
1,794,252
+201,671
| +13% | +$19.7M | 0.52% | 47 |
|
|
2022
Q1 | $161M | Buy |
1,592,581
+79,332
| +5% | +$8.33M | 0.38% | 64 |
|
|
2021
Q4 | $156M | Sell |
1,513,249
-60,029
| -4% | -$5.55M | 0.33% | 78 |
|
|
2021
Q3 | $134M | Buy |
1,573,278
+41,849
| +3% | +$3.51M | 0.3% | 91 |
|
|
2021
Q2 | $128M | Buy |
1,531,429
+173,543
| +13% | +$14.2M | 0.28% | 96 |
|
|
2021
Q1 | $102M | Buy |
1,357,886
+8,514
| +0.6% | +$620K | 0.25% | 103 |
|
|
2020
Q4 | $92.2M | Buy |
1,349,372
+17,606
| +1% | +$1.15M | 0.24% | 100 |
|
|
2020
Q3 | $77.8M | Buy |
1,331,766
+314,890
| +31% | +$19.6M | 0.24% | 109 |
|
|
2020
Q2 | $66.1M | Buy |
1,016,876
+411,595
| +68% | +$25.9M | 0.22% | 113 |
|
|
2020
Q1 | $35.9M | Buy |
605,281
+55,272
| +10% | +$3.69M | 0.14% | 188 |
|
|
2019
Q4 | $40.9M | Buy |
550,009
+15,845
| +3% | +$1.11M | 0.13% | 215 |
|
|
2019
Q3 | $33.7M | Buy |
534,164
+15,957
| +3% | +$946K | 0.12% | 225 |
|
|
2019
Q2 | $28.2M | Sell |
518,207
-20,101
| -4% | -$1.08M | 0.1% | 266 |
|
|
2019
Q1 | $29M | Sell |
538,308
-109,633
| -17% | -$6.77M | 0.11% | 262 |
|
|
2018
Q4 | $42.4M | Buy |
647,941
+119,752
| +23% | +$8.94M | 0.19% | 151 |
|
|
2018
Q3 | $41.6M | Sell |
528,189
-21,404
| -4% | -$1.53M | 0.16% | 171 |
|
|
2018
Q2 | $35.4M | Sell |
549,593
-135,660
| -20% | -$8.94M | 0.16% | 169 |
|
|
2018
Q1 | $42.6M | Buy |
685,253
+757
| +0.1% | +$54.3K | 0.2% | 136 |
|
|
2017
Q4 | $49.6M | Buy |
684,496
+294,246
| +75% | +$21.4M | 0.26% | 110 |
|
|
2017
Q3 | $31.7M | Buy |
390,250
+114,908
| +42% | +$9.09M | 0.2% | 142 |
|
|
2017
Q2 | $22.2M | Sell |
275,342
-214,600
| -44% | -$16.9M | 0.14% | 183 |
|
|
2017
Q1 | $38.5M | Buy |
489,942
+114,349
| +30% | +$9.13M | 0.26% | 116 |
|
|
2016
Q4 | $29.6M | Sell |
375,593
-828,889
| -69% | -$67.1M | 0.23% | 131 |
|
|
2016
Q3 | $107M | Sell |
1,204,482
-558,324
| -32% | -$52.7M | 0.79% | 19 |
|
|
2016
Q2 | $169M | Sell |
1,762,806
-20,522
| -1% | -$2.05M | 1.28% | 6 |
|
|
2016
Q1 | $185M | Buy |
1,783,328
+313,289
| +21% | +$30.5M | 1.48% | 4 |
|
|
2015
Q4 | $144M | Sell |
1,470,039
-452,807
| -24% | -$44.3M | 1.23% | 8 |
|
|
2015
Q3 | $186M | Sell |
1,922,846
-139,723
| -7% | -$14.7M | 1.41% | 6 |
|
|
2015
Q2 | $216M | Sell |
2,062,569
-143,044
| -6% | -$14.6M | 1.64% | 3 |
|
|
2015
Q1 | $228M | Sell |
2,205,613
-212,161
| -9% | -$21.5M | 1.71% | 3 |
|
|
2014
Q4 | $233M | Sell |
2,417,774
-483,305
| -17% | -$42.6M | 1.67% | 5 |
|
|
2014
Q3 | $231M | Sell |
2,901,079
-8,740
| -0.3% | -$689K | 1.65% | 7 |
|
|
2014
Q2 | $219M | Sell |
2,909,819
-43,586
| -1% | -$3.29M | 1.57% | 7 |
|
|
2014
Q1 | $221M | Buy |
2,953,405
+361,741
| +14% | +$25.6M | 1.7% | 7 |
|
|
2013
Q4 | $185M | Buy |
2,591,664
+89,907
| +4% | +$5.78M | 1.54% | 9 |
|
|
2013
Q3 | $142M | Buy |
2,501,757
+53,260
| +2% | +$3.17M | 1.38% | 11 |
|
|
2013
Q2 | $140M | Buy |
+2,448,497
| New | +$142M | 1.42% | 11 |
|
Other funds holding CVS
LMFP
CF
HCM
FWIA
MIF
Robeco Institutional Asset Management's CVS Position: Q2 2026 in Review
Robeco Institutional Asset Management reduced its CVS Health (CVS) stake by 15% in Q2 2026, selling an estimated $30.4M and leaving 2,008,760 shares worth $208M. The position accounts for 0.26% of the portfolio, ranked #93.
Robeco Institutional Asset Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $265M in Q4 2025. 547 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Robeco Institutional Asset Management held 2,008,760 shares of CVS Health worth $208M as of Q2 2026.
- Robeco Institutional Asset Management sold 340,684 CVS Health shares in Q2 2026, an estimated $30.4M.
- CVS Health made up 0.26% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #93 holding.
- Robeco Institutional Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Robeco Institutional Asset Management's CVS Health position peaked at $265M in Q4 2025.
- 547 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.